Newsletter | July 11, 2026

07.11.26 -- Cell & Gene Newsletter - Best Of June

FROM THE EDITOR

Hello Cell & Gene readers,

 

I'm happy to bring you June's most-clicked articles. Enjoy!

 

Erin Harris, editor-in-chief  
Follow me on X

JUNE'S BEST FEATURED EDITORIAL

Inside AstraZeneca's Fully Electrified Cell Therapy Facility

The company won an ISPE FOYA for its Rockville, Maryland, manufacturing site that boasts 100% uptime and flexible capacity to produce thousands of batches annually.

Why Cell And Gene Therapy Has Not Reached More Patients — And Why Clinical Operations Is The Bridge

Cell and gene therapy (CGT) has already changed oncology and rare disease care. The next challenge is translating scientific possibility into credible evidence.

Driving Gene Therapy Beyond Rare Disease Will Define The Next Era Of CGT

Gene therapy’s next test is not proving it works, but proving it can scale.

JUNE'S BEST INDUSTRY INSIGHTS

Improving Next-Generation Sequencing Workflows With Droplet Digital PCR

Optimize NGS workflows by using digital PCR for absolute quantification. Improve library quality, reduce bias, and gain sensitive validation for rare variants in complex genomic samples.

Separation Of cfDNA With An NGS Kit On Fragment Analyzer Systems

Learn how precise sizing methods reveal nucleosome patterns in cfDNA and help distinguish true signal from extraction‑related artifacts for more reliable genomic analysis.

The Spirit Of MISEV

MISEV guidelines help extracellular vesicle researchers design robust experiments through transparent reporting and rigorous characterization rather than rigid checklists.

JUNE'S BEST SOLUTIONS

Electroporation For Discovery And Screening

Explore A New Imaging System That Offers Faster Scans

A Revolutionary Consumable For High-Throughput Organ-Chip Studies

Connect With Cell & Gene: